[18F] Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) assesses a
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique …

Multimodality imaging, as represented by its greatest exponent, PET/CT, has a firm place in
the evaluation of a patient presenting with cancer. With 18F-FDG, PET/CT is rapidly …

Purpose Standardized response criteria are needed to interpret and compare clinical trials
and for approval of new therapeutic agents by regulatory agencies. Methods The …

Purpose Interim positron emission tomography (PET) using the tracer,[18F]
fluorodeoxyglucose, may predict outcomes in patients with aggressive non-Hodgkin …

Purpose To develop guidelines for performing and interpreting positron emission
tomography (PET) imaging for treatment assessment in patients with lymphoma both in …

Diffuse large B-cell lymphomas (DLBCLs) and follicular lymphoma (FL) are the most
common subtypes of B-cell non-Hodgkin's lymphomas in adults. Histologic transformation of …

1Department of Haematology, Queen Elizabeth Hospital, Birmingham, 2Department of
Clinical Oncology, Christie Hospital, Manchester, 3PET Imaging Centre, King's College …

18-F-fluorodeoxyglucose (FDG)–positron emission tomography (PET), and more recently
PET/computed tomography (CT), is the most sensitive and specific imaging technique …

To identify prognostic factors for patients transplanted for relapsed or refractory Hodgkin
lymphoma we carried out a combined analysis of patients followed prospectively on 3 …

PET with the glucose analog 18F-FDG is increasingly used to monitor tumor response in
patients undergoing chemotherapy and chemoradiotherapy. Numerous studies have shown …